We use cookies to improve our services and to provide you with tailored content for an improved experience. By clicking "Accept", you consent to cookies.
Your request has been successfully queued and will be available in your order history shortly. We will follow up to confirm your prescription and provide the next steps.
There have been news stories lately (here’s one) about how the rates of STDs among America’s (clearly) active seniors has skyrocketed lately. We’re talking a 24% jump from 2020 to 2023 among patients 65 and older, and about a 16% increase in those 55 to 64.
That said, there wasn’t a lot of explanation for the jump. Better health overall? Better medications for sexual health? Infrequent condom use? Discounts on Barry
Millions of men are affected by erectile dysfunction to some degree and the vast majority of those men are actively searching for the best therapy available. From the good old "Viva Viagra" TV commercials to today's mass marketing machines of Hims, Roman, and others, men have been conditioned to believe the oral ED tablets (PDE5 Inhibitors) like sildenafil and tadalafil are the only option they have available. If I may quote the immortal Lee Corso, "Not so fast!" Men have many other options available and many offer significant benefits over the little blue pill.
To be clear, PDE5 tablets have been and will be important therapeutic options for men with ED, but many men cannot use them for any number of reasons. For some men, they simply don't work. For others, there are medical
By The Revelation Pharma Marketing Team / Lexi J., BHA., MBA (Marketing Assoc. of Patient Partnerships), Haleigh Wilkes, PharmD., & Joseph Drummond, PharmD.
In the world of pharmaceuticals, compounding pharmacies play a critical role in tailoring medications to meet the unique needs of patients. But not all compounding pharmacies are created equal. There are two primary types: 503A and 503B. Understanding the differences between these two can help you make more informed decisions about your healthcare. In this article, we'll break down these distinctions and explore the relevance of this topic to Revelation Pharma and the communities we serve.
Understanding 503A and 503B Compounding Pharmacies
The distinction between 503A and 503B compounding pharmacies stems from the Drug Quality and Security Act (DQSA) of 2013. This act was introduced to enhance the safety and quality of compounded medications.
Compounders can help relieve drug shortages, says Revelation Pharma’s CEO, but they need help from the FDA. Shawn Hodges was interviewed for the latest edition of Pharmaceutical Executive for a piece called “Drug Shortages May Have a Compounding Solution” where he discussed how 503B pharmacies can fill the gaps caused by commercial pharma shortages and logistics issues.
“If you look at the problem in general, the shortages are being caused by manufacturing problems, supply chain issues, economic factors, and regulatory issues. There are opportunities in certain instances where compounding pharmacies can fill the void until the manufacturers are able to produce the products.”
Shawn is just one of the amazing team members at Revelation
